Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
1.
Bull World Health Organ ; 97(5): 335-348, 2019 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-31551630

RESUMEN

Health financing is a complex health system function, which cannot be analysed accurately without tracking each step of the flow of funds separately. We analysed the revenue mix of the Hungarian health insurance fund from 1994 to 2015 and discuss the policy implications of our findings. We used the System of Health Accounts published in 2000 and the revised version of 2011, which introduced separate classifications for the sources of health expenditure. Based on the 2000 version, health insurance contributions were the main source of public funding in Hungary. According to the 2011 version, nearly 70% of health insurance fund revenues came from government tax transfers in 2015, illustrating the striking difference in how revenues and expenditures are reported using this version. Use of the 2011 version will better inform national policy-making and international comparisons and facilitate documentation and analysis of how countries have adapted their revenue mix to changing macroeconomic circumstances. The finding that Hungary has a predominantly tax-funded social health insurance system suggests that traditional understanding and description of health-financing models are no longer adequate and may limit consideration of potential resource-generation options. Hungary is also a good example of how separating revenue generation and pooling broadens policy options to tackle gaps in social health insurance coverage, although the government did not act on these due to the lack of a consistent health-financing strategy. The findings may be particularly relevant for low- and middle-income countries that are trying to expand social health insurance coverage despite limited formal employment.


Le financement de la santé est une fonction complexe du système de santé, qui ne peut pas être précisément analysée sans étudier séparément chaque étape du flux de fonds. Dans cet article, nous analysons le mix de recettes du fonds d'assurance maladie hongrois de 1994 à 2015 et nous évoquons les implications de nos constatations sur la définition des politiques. Nous avons utilisé le Système des Comptes de la Santé publié en 2000 ainsi que sa version révisée de 2011, qui a introduit des classifications différentes pour les sources des dépenses de santé. En se fondant sur la version de 2000, ce sont les cotisations d'assurance maladie qui ont constitué la principale source de financement public en Hongrie. Mais d'après la version de 2011, près de 70% des recettes constitutives des fonds de l'assurance maladie sont provenues de transferts fiscaux gouvernementaux en 2015, ce qui illustre la différence flagrante dans la manière d'enregistrer les recettes et les dépenses proposée par cette version révisée. L'utilisation de la version de 2011 permettra de mieux informer le processus d'élaboration des politiques nationales, de faciliter les comparaisons internationales ainsi que de mieux documenter et analyser la manière dont les pays adaptent leur mix de recettes face à l'évolution des circonstances macroéconomiques. Le fait que le système d'assurance maladie sociale de Hongrie s'avère principalement financé par l'impôt montre que la compréhension et la description habituelles des modèles de financement de la santé ne sont plus adaptées et que cela peut même entraver la considération d'autres options envisageables pour générer des recettes. La Hongrie est également un bon exemple illustrant comment le fait de séparer la génération des recettes et la mise en commun des fonds élargit les options politiques pour réduire les déficiences dans la couverture de l'assurance maladie sociale, même si le gouvernement n'a pas agi sur ce point, faute de stratégie de financement de la santé cohérente en la matière. Ces constatations peuvent être particulièrement utiles pour les pays à revenu faible et intermédiaire qui essayent d'étendre la couverture de leur assurance maladie sociale malgré un niveau d'emploi limité dans le secteur formel.


La financiación de la salud es una función compleja del sistema sanitario que no puede analizarse con precisión si no se hace un seguimiento independiente de cada paso del flujo de fondos. Se ha analizado la combinación de ingresos de la caja húngara de seguros médicos de 1994 a 2015 y se han discutido las implicaciones políticas de los resultados. Se ha usado el Sistema de Cuentas de Salud publicado en 2000 y la versión revisada de 2011, que introdujo las clasificaciones separadas para las fuentes de gasto en salud. Según la versión de 2000, las cotizaciones al seguro de enfermedad eran la principal fuente de financiación pública en Hungría. Según la versión de 2011, casi el 70 % de los ingresos de la caja de seguros médicos procedían de las transferencias de impuestos del gobierno en 2015, lo que ilustra la sorprendente diferencia en la forma en que se informan los ingresos y los gastos utilizando esta versión. El uso de la versión de 2011 servirá de base para la formulación de políticas nacionales y comparaciones internacionales y facilitará la documentación y el análisis de cómo los países han adaptado su combinación de ingresos a las cambiantes circunstancias macroeconómicas. La conclusión de que Hungría tiene un sistema de seguridad social financiada principalmente por los impuestos sugiere que la comprensión y la descripción tradicionales de los modelos de financiación sanitaria ya no son adecuados y limitan la consideración de las posibles opciones de generación de recursos. Hungría es también un buen ejemplo de cómo la separación entre la generación de ingresos y la puesta en común amplía las opciones políticas para abordar las brechas en la cobertura de la seguridad social, aunque el gobierno no haya actuado al respecto debido a la falta de una estrategia coherente de financiación sanitaria. Las conclusiones pueden ser particularmente pertinentes para los países de ingresos bajos y medianos que estén tratando de ampliar la cobertura de la seguridad social a pesar de la limitación del empleo formal.


Asunto(s)
Financiación de la Atención de la Salud , Seguro de Salud/economía , Sistema de Pago Simple/economía , Impuestos/economía , Administración Financiera , Financiación Gubernamental , Política de Salud , Humanos , Hungría
2.
Bull World Health Organ ; 96(9): 599-609, 2018 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-30262941

RESUMEN

OBJECTIVE: To investigate the equity and policy implications of different methods to calculate catastrophic health spending. METHODS: We used routinely collected data from recent household budget surveys in 14 European countries. We calculated the incidence of catastrophic health spending and its distribution across consumption quintiles using four methods. We compared the budget share method, which is used to monitor universal health coverage (UHC) in the sustainable development goals (SDGs), with three other well-established methods: actual food spending; partial normative food spending; and normative spending on food, housing and utilities. FINDINGS: Country estimates of the incidence of catastrophic health spending were generally similar using the normative spending on food, housing and utilities method and the budget share method at the 10% threshold of a household's ability to pay. The former method found that catastrophic spending was concentrated in the poorest quintile in all countries, whereas with the budget share method catastrophic spending was largely experienced by richer households. This is because the threshold for catastrophic health spending in the budget share method is the same for all households, while the other methods generated effective thresholds that varied across households. The normative spending on food, housing and utilities method was the only one that produced an effective threshold that rose smoothly with total household expenditure. CONCLUSION: The budget share method used in the SDGs overestimates financial hardship among rich households and underestimates hardship among poor households. This raises concerns about the ability of the SDG process to generate appropriate guidance for policy on UHC.


Asunto(s)
Enfermedad Catastrófica/economía , Costo de Enfermedad , Gastos en Salud , Cobertura Universal del Seguro de Salud , Adulto , Niño , Europa (Continente) , Financiación Personal , Política de Salud , Humanos
3.
Lancet Reg Health Eur ; 37: 100826, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38362555

RESUMEN

Background: Ensuring that access to health care is affordable for everyone-financial protection-is central to universal health coverage (UHC). Financial protection is commonly measured using indicators of financial barriers to access (unmet need for health care) and financial hardship caused by out-of-pocket payments for health care (impoverishing and catastrophic health spending). We aim to assess financial hardship and unmet need in Europe and identify the coverage policy choices that undermine financial protection. Methods: We carry out a cross-sectional study of financial hardship in 40 countries in Europe in 2019 (the latest available year of data before COVID-19) using microdata from national household budget surveys. We define impoverishing health spending as out-of-pocket payments that push households below or further below a relative poverty line and catastrophic health spending as out-of-pocket payments that exceed 40% of a household's capacity to pay for health care. We link these results to survey data on unmet need for health care, dental care, and prescribed medicines and information on two aspects of coverage policy at country level: the main basis for entitlement to publicly financed health care and user charges for covered services. Findings: Out-of-pocket payments for health care lead to financial hardship and unmet need in every country in the study, particularly for people with low incomes. Impoverishing health spending ranges from under 1% of households (in six countries) to 12%, with a median of 3%. Catastrophic health spending ranges from under 1% of households (in two countries) to 20%, with a median of 6%. Catastrophic health spending is consistently concentrated in the poorest fifth of the population and is largely driven by out-of-pocket payments for outpatient medicines, medical products, and dental care-all forms of treatment that should be an essential part of primary care. The median incidence of catastrophic health spending is three times lower in countries that cover over 99% of the population than in countries that cover less than 99%. In 16 out of the 17 countries that cover less than 99% of the population, the basis for entitlement is payment of contributions to a social health insurance (SHI) scheme. Countries that give greater protection from user charges to people with low incomes have lower levels of catastrophic health spending. Interpretation: It is challenging to identify with certainty the coverage policy choices that undermine financial protection due to the complexity of the policies involved and the difficulty of disentangling the effects of different choices. The conclusions we draw are therefore tentative, though plausible. Countries are more likely to move towards UHC if they reduce out-of-pocket payments in a progressive way, decreasing them for people with low incomes first. Coverage policy choices that seem likely to achieve this include de-linking entitlement from payment of SHI contributions; expanding the coverage of outpatient medicines, medical products, and dental care; limiting user charges; and strengthening protection against user charges, particularly for people with low incomes. Funding: The European Union (DG SANTE and DG NEAR) and the Government of the Autonomous Community of Catalonia, Spain.

4.
Health Policy ; 147: 105136, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-39089167

RESUMEN

Progress towards universal health coverage is monitored by the incidence of catastrophic spending. Two catastrophic spending indicators are commonly used in Europe: Sustainable Development Goal (SDG) indicator 3.8.2 and the WHO Regional Office for Europe (WHO/Europe) indicator. The use of different indicators can cause confusion, especially if they produce contradictory results and policy implications. We use harmonised household budget survey data from 27 European Union countries covering 505,217 households and estimate the risk of catastrophic spending, conditional on household characteristics and the design of medicines co-payments. We calculate the predicted probability of catastrophic spending for particular households, which we call LISAs, under combinations of medicines co-payment policies and compare predictions across the two indicators. Using the WHO/Europe indicator, any combination of two or more protective policies (i.e. low fixed co-payments instead of percentage co-payments, exemptions for low-income households and income-related caps on co-payments) is associated with a statistically significant lower risk of catastrophic spending. Using the SDG indicator, confidence intervals for every combination of protective policies overlap with those for no protective policies. Although out-of-pocket medicines spending is a strong predictor of catastrophic spending using both indicators, the WHO/Europe indicator is more sensitive to medicines co-payment policies than the SDG indicator, making it a better indicator to monitor health system equity and progress towards UHC in Europe.


Asunto(s)
Gastos en Salud , Cobertura Universal del Seguro de Salud , Humanos , Europa (Continente) , Gastos en Salud/estadística & datos numéricos , Cobertura Universal del Seguro de Salud/economía , Política de Salud , Financiación Personal , Composición Familiar , Enfermedad Catastrófica/economía
5.
Soc Sci Med ; 320: 115168, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-36822716

RESUMEN

Despite limited evidence of successful development and implementation of contributory health insurance and low and middle income countries, many countries are in the process implementing such schemes. This commentary summarizes all available evidence on the limitations of contributory health insurance including the lack of good theoretical underpinning and the considerable evidence of inequity and fragmentation created by such schemes. Moreover, the initiation of a contributory health insurance scheme has not been found to increase revenues to the health sector or help health countries achieve universal health coverage. Low and middle income countries can improve equity and efficiency of the health sector by replacing out-of-pocket spending with pre-paid pooling mechanisms, but that is best done through budget transfers and not by contributory insurance that links payment to sub-population entitlements.


Asunto(s)
Países en Desarrollo , Seguro de Salud , Humanos , Gastos en Salud , Cobertura Universal del Seguro de Salud
6.
Health Policy ; 126(1): 7-15, 2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-34857406

RESUMEN

The COVID-19 pandemic triggered an economic shock just ten years after the shock of the 2008 global financial crisis. Economic shocks are a challenge for health systems because they reduce government revenue at the same time as they increase the need for publicly financed health care. This article explores the resilience of health financing policy to economic shocks by reviewing policy responses to the financial crisis and COVID-19 in Europe. It finds that some health systems were weakened by responses to the 2008 crisis. Responses to the pandemic show evidence of lessons learnt from the earlier crisis but also reveal weaknesses in health financing policy that limit national preparedness to face economic shocks, particularly in countries with social health insurance schemes. These weaknesses highlight where permanent changes are needed to strengthen resilience in future: countries will have to find ways to reduce cyclicality in coverage policy and revenue-raising; increase the priority given to health in allocating public spending; and ensure that resources are used to meet equity and efficiency goals. Although many health systems are likely to face budgetary pressure in the years ahead, the experience of the 2008 crisis shows that austerity is not an option because it undermines resilience and progress towards universal health coverage.


Asunto(s)
COVID-19 , Financiación de la Atención de la Salud , Europa (Continente) , Política de Salud , Humanos , Pandemias/prevención & control , SARS-CoV-2
7.
Health Policy Plan ; 36(8): 1307-1315, 2021 Sep 09.
Artículo en Inglés | MEDLINE | ID: mdl-33855342

RESUMEN

Efficiency has historically been considered a key mechanism to increase the amount of available revenues to the health sector, enabling countries to expand services and benefits to progress towards universal health coverage (UHC). Country experience indicates, however, that efficiency gains do not automatically translate into greater budget for health, to additional revenues for the sector. This article proposes a framework to assess whether and how efficiency interventions are likely to increase budgetary space in health systems Based on a review of the literature and country experiences, we suggest three enabling conditions that must be met in order to transform efficiency gains into budgetary gains for health. First there must be well-defined efficiency interventions that target health system inputs, implemented over a medium-term time frame. Second, efficiency interventions must generate financial gains that are quantifiable either pre- or post-intervention. Third, public financial management systems must allow those gains to be kept within the health sector and repurposed towards priority health needs. When these conditions are not met, efficiency gains do not lead to more budgetary space for health. Rather, the gains may instead result in budget cuts that can be detrimental to health systems' outputs and ultimately disincentivize further attempts to improve efficiency in the sector. The framework, when applied, offers an opportunity for policymakers to reconcile efficiency and budget expansion goals in health.


Asunto(s)
Administración Financiera , Cobertura Universal del Seguro de Salud , Presupuestos , Prioridades en Salud , Humanos
8.
Lege Artis Med ; 20(5): 331-8, 2010 May.
Artículo en Húngaro | MEDLINE | ID: mdl-20533704

RESUMEN

Policy makers and payers of health care services devote increasing attention to improve quality of services by incentivising health care providers. These--so called--pay for performance (P4P) programmes have so far been introduced in few countries only and evidence on their effectiveness is still scarce. Therefore we do not know yet which instruments of these programmes are most effective and efficient in improving quality. The P4P systems implemented so far in primary care and in integrated delivery systems use indicators for measurement of performance and the basis for rewards. These indicators are mostly process indicators, but there are some outcome indicators as well. The desired quality improvement effects are most likely to be achieved with programmes that provide seizable financial rewards and cover the extra cost of quality improvement efforts as well. Administration of the programme has to be fully transparent and clear to all involved. It has to be based on scientific evidence and supported with sufficient dedicated funding. Conducting pilot studies is a precondition for large scale implementation.


Asunto(s)
Política de Salud/economía , Planes de Incentivos para los Médicos/economía , Pautas de la Práctica en Medicina/economía , Atención Primaria de Salud/economía , Garantía de la Calidad de Atención de Salud/economía , Reembolso de Incentivo/economía , Política de Salud/tendencias , Humanos , Hungría , Evaluación de Resultado en la Atención de Salud/economía , Satisfacción del Paciente , Desarrollo de Programa , Evaluación de Programas y Proyectos de Salud , Garantía de la Calidad de Atención de Salud/métodos , Garantía de la Calidad de Atención de Salud/tendencias , Reembolso de Incentivo/tendencias
9.
Health Policy ; 77(1): 86-102, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16140416

RESUMEN

While there is a growing body of evidence that informal payments for health care are widespread and enduring in the former communist countries of Central and Eastern Europe and Central Asia, evidence on the scale of the phenomenon is not only limited, but what is available is often conflicting. Hungary exemplifies this controversy, as the available literature provides conflicting figures, differing by an order of magnitude among various surveys, with a similarly large difference between survey findings and expert estimates. This study advances understanding of the methodological issues involved in researching informal payments by providing a systematic analysis of the methodology of available empirical research and official statistics on the scale of informal payments in Hungary. The paper explores the potential sources of differences, to assess the scope to reduce the differences between various estimates and to define the upper and lower boundaries within which the true magnitude of informal payments can be expected to lie. Our analysis suggests that in 2001 the overall magnitude of informal payments lay between 16.2 and 50.9 billion HUF (euro 64.8- euro 203.6 million, US dollars 77.1-242.4 million), which amounted to 1.5-4.6% of total health expenditures in Hungary. Looked at this way, informal payments do not seem to be an important source of health care financing. However, as informal payments are unequally distributed among health workers, with the bulk of the money going to physicians, with some not taking any informal payments, family doctors and some specialists may have earned between 60 and 236% of their net official income from this source in 2001. This suggests that it is not the overall amount of informal payment that makes it a policy concern, but the consequences of its unequal distribution among health workers. What is remarkable about informal payments in Hungary is that a relatively small amount of money can keep the system running, which gives rise to the hypothesis that, in certain cases, it is the hope of substantial informal payments in the future that motivates physicians to remain in the system. This is a difficult challenge for policy-makers as it would require a much larger amount of money to achieve equilibrium under any formal alternative.


Asunto(s)
Atención a la Salud/economía , Financiación Personal/estadística & datos numéricos , Investigación sobre Servicios de Salud/métodos , Humanos , Hungría
10.
Value Health Reg Issues ; 7: 27-33, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29698149

RESUMEN

OBJECTIVES: The aim of this article was to provide a description of the Hungarian care managing organization (CMO) pilot program and its environment, incentive structure, and preliminary outcomes. The need to change the behavior of doctors to increase the effectiveness and cost-effectiveness of the system was the key rationale for the Hungarian CMO pilot program. METHODS: After an application process, nine CMOs were entitled to enter into the system in July 1999. By 2006, there were 14 CMOs covering 2.1 million people. The Hungarian CMO program tried to combine the advantages of both the US managed care programs and the UK general practitioner fundholding system, within the constraints and opportunities of a Central-European country committed to a single-payer health insurance system. RESULTS: The revenue of CMOs derived from a risk-adjusted capitation. The capitation formula was weighted only by age and sex. The expenditures of the CMOs included all the health expenditures on their patients that occurred in any part of the health care system. The average savings rate for all CMOs for the fiscal years 1999 to 2007 was 4.94%. The highest rates of savings were realized in chronic and acute inpatient care and medical devices. The pilot was discontinued in 2008 without a comprehensive evaluation of the experience. CONCLUSIONS: We can conclude that this pilot had a significant contribution to the modernization of the Hungarian health care system.

11.
Eur J Health Econ ; 11(2): 227-33, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19593629

RESUMEN

Since 2002, the Croatian social health insurance system has undergone substantial reforms, initiated for the most part with the aim of addressing the perpetual financial deficits of the state health insurance fund. While the reforms focussed heavily on increasing the inflow of private funds into the health care system, underlying inefficiencies contributing significantly to poor financial performance have been largely ignored. Furthermore, contrary to demographic trends and developments in social health insurance schemes in other countries, funding health care became even more dependent on its main collection mechanism-payroll tax-and consequently on the employment ratio and wage level. Little effort has been made to diversify the revenue base or to increase the efficiency of revenue collection. Like other countries, Croatia is facing difficulties in adjusting its 'Bismarck' system to its changing demographic and socioeconomic context. Instead of targetting a comprehensive effort at improving revenue collection and limitating unnecessary expenditure and system inefficiencies, simplified approaches to balance the budget have been implemented at a high price to users and with limited effect. As a result, the Croatian health insurance system now offers a lower level of financial protection, while still facing the problem of spending more than can be collected through the current mix of revenue collection mechanisms. The authors suggest that, in order to meet the sustainability requirement of the health financing system, measures affecting both revenue and expenditure should be considered and implemented. On the revenue collection side, the Croatian government must make further efforts to improve collection from the informally employed to broaden the base of contributing members; equally important is the diversification of revenue sources by increasing transfers from general taxation revenues. On the expenditure side, exploring inefficiencies of the delivery system can be delayed no longer, and the introduction of effective cost-control mechanisms and financial discipline would seem to be unavoidable.


Asunto(s)
Financiación Gubernamental/métodos , Reforma de la Atención de Salud/economía , Política de Salud/economía , Seguro de Salud/economía , Seguro de Salud/estadística & datos numéricos , Medicina Estatal/economía , Croacia , Toma de Decisiones en la Organización , Financiación Gubernamental/economía , Financiación Personal/economía , Reforma de la Atención de Salud/legislación & jurisprudencia , Gastos en Salud , Humanos , Seguro de Salud/organización & administración , Política , Factores Socioeconómicos , Medicina Estatal/organización & administración , Impuestos/economía
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda